More often, overexpression of KDM5A is an oncogenic driver; high levels of KDM5A are observed across a wide variety of cancerous cells, including glioblastomas, breast, lung, and ovarian cancers [12–17]. This evidence concerns the gene KDM5A and ovarian cancer.